TRAX First Tracks Biotherapeutics, Inc.

NASDAQ
$40.46

First Tracks Biotherapeutics, Inc. (TRAX) Seasonality

What this stock has historically done over the three months following this point in the calendar year, measured against every other three-month stretch on record.

Not enough price history for TRAX to build a seasonal study.